Therapeutic Agent Toxicology Practice Quiz (25 questions)

All questions and answers

1. Compared with barbiturates, what feature helped benzodiazepines replace them in clinical use?

A lower therapeutic index and lack of anesthetic properties
More frequent respiratory depression and anesthetic properties
A higher therapeutic index and anesthetic properties
A higher therapeutic index and lack of anesthetic properties

A higher therapeutic index and lack of anesthetic properties

Explanation

Benzodiazepines have a higher therapeutic index than barbiturates and lack anesthetic properties, supporting their substitution. A lower therapeutic index reverses the safety comparison, anesthetic properties misstate the distinction, and greater respiratory toxicity is not the stated reason.

2. A patient takes a very large dose of a benzodiazepine. Which progression best fits the principal mechanism of toxicity?

Cardiac stimulation, followed by smooth and skeletal muscle activation
Central nervous system depression, with muscle depression and possible respiratory depression
Respiratory depression first, followed by central nervous system stimulation
Muscle depression first, followed by central nervous system stimulation

Central nervous system depression, with muscle depression and possible respiratory depression

Explanation

Benzodiazepine toxicity mainly depresses the central nervous system, leading to smooth, skeletal, and cardiac muscle depression; respiratory depression may occur at higher doses. Respiratory depression is not the stated first effect, cardiac stimulation reverses the direction, and central nervous system stimulation contradicts the mechanism.

3. A patient develops benzodiazepine overdose after receiving the drug parenterally. Which expectation best reflects the typical risk pattern?

Overall morbidity and mortality are relatively low, but respiratory depression and hypotension are more likely
Overall morbidity and mortality are high, but respiratory depression and hypotension are less likely
Overall morbidity and mortality are relatively low, and respiratory depression and hypotension are less likely
Overall morbidity and mortality are high, and respiratory depression and hypotension are more likely

Overall morbidity and mortality are relatively low, but respiratory depression and hypotension are more likely

Explanation

Benzodiazepine overdose generally has relatively low morbidity and mortality, while respiratory depression and hypotension occur more often with parenteral administration. High overall mortality overstates the typical outcome, and describing these complications as less likely reverses the route-related risk.

4. A hospitalized patient needs reversal of benzodiazepine-induced sedation and muscle relaxation. Which treatment matches the specified antagonist and route?

Intravenous diazepam
Oral flumazenil
Intravenous flumazenil
Intravenous naloxone

Intravenous flumazenil

Explanation

Flumazenil is the benzodiazepine antagonist used intravenously and can reverse sedative and muscle-relaxant effects. Oral flumazenil uses the wrong route, diazepam is a benzodiazepine rather than its antagonist, and naloxone is an opioid antagonist.

5. A patient receiving lithium develops signs of intoxication despite taking a prescribed dose. Which property best explains why toxicity can occur relatively frequently during therapy?

Lithium has a wide therapeutic index
Lithium has a narrow therapeutic index
Lithium has a broad therapeutic range
Lithium has a high therapeutic index

Lithium has a narrow therapeutic index

Explanation

Lithium's narrow therapeutic index means the range between therapeutic and toxic exposure is limited, making intoxication a relatively frequent complication of therapy. A wide or broad range implies the opposite, while a high therapeutic index does not explain this risk.

6. A patient who is pregnant is being evaluated for lithium therapy. What is the appropriate concern-based recommendation?

Avoid lithium because it primarily causes maternal cardiac anomalies
Avoid lithium because it is teratogenic and can cause fetal cardiac anomalies
Use lithium because it prevents fetal cardiac anomalies
Continue lithium because it has no known fetal effects

Avoid lithium because it is teratogenic and can cause fetal cardiac anomalies

Explanation

Lithium should not be taken during pregnancy because it is teratogenic and can cause cardiac anomalies in the fetus. Claiming it prevents anomalies reverses the risk, maternal cardiac effects misidentify who is affected, and denying fetal effects contradicts the stated concern.

7. Which mechanism best describes how lithium toxicity affects the nervous system?

It affects the central nervous system, releases several ions from intracellular sites, and leaves receptor sensitivity unchanged
It affects the central nervous system, competes with several ions for intracellular sites, and alters receptor sensitivity and neurotransmission
It affects the peripheral nervous system, competes with several ions outside cells, and increases receptor sensitivity without changing neurotransmission
It affects the central nervous system, competes with several ions for extracellular sites, and reduces neurotransmission by blocking all receptors

It affects the central nervous system, competes with several ions for intracellular sites, and alters receptor sensitivity and neurotransmission

Explanation

Lithium toxicity affects the central nervous system, competes with sodium, potassium, magnesium, and calcium for intracellular sites, and alters receptor sensitivity and neurotransmission through biochemical mechanisms. Ion release reverses the competition, an exclusively peripheral effect mislocates the primary system, and extracellular competition or blanket receptor blockade misstates the mechanism.

8. Which description best defines an opioid?

A psychoactive chemical that resembles morphine’s effects and binds opioid receptors
A psychoactive chemical that resembles morphine’s effects by inhibiting metabolic enzymes
A chemical that resembles morphine’s effects by binding mainly to muscarinic receptors
A natural alkaloid from opium-poppy resin that does not include synthetic drugs

A psychoactive chemical that resembles morphine’s effects and binds opioid receptors

Explanation

An opioid resembles morphine or other opiates in pharmacological effects and acts by binding opioid receptors, found principally in the central and peripheral nervous systems and gastrointestinal tract. Enzyme inhibition, limiting the term to natural opiates, and muscarinic binding each misstate this definition.

9. A student uses “opiate” for a natural alkaloid from opium-poppy resin and “opioid” for the broader class that also includes synthetic substances and opioid peptides. Which distinction is the student applying?

Opiates and opioids are distinguished by whether they cause sedation or stimulation
Opiates and opioids are distinguished by whether they bind central or peripheral receptors
Opiates are natural alkaloids; opioids include opiates, synthetic substances, and opioid peptides
Opioids are natural alkaloids; opiates include synthetic substances and opioid peptides

Opiates are natural alkaloids; opioids include opiates, synthetic substances, and opioid peptides

Explanation

“Opiate” is limited to natural alkaloids in opium-poppy resin, whereas “opioid” includes opiates, synthetic substances, and opioid peptides. Reversing the terms, using receptor location, or relying on clinical effects does not express the source-based distinction.

10. A patient with suspected opioid toxicity develops depressed breathing, pinpoint pupils, a slow heart rate, and reduced bowel motility. Which interpretation best fits this presentation?

A pattern consistent with antimuscarinic toxicity
A pattern consistent with isolated opioid withdrawal
A pattern consistent with sympathomimetic toxicity
A pattern consistent with opioid toxicity

A pattern consistent with opioid toxicity

Explanation

Opioid toxicity can produce central nervous system and respiratory depression, miosis, bradycardia, and decreased gastrointestinal motility. Sympathetic overactivity, stimulant-associated pupil changes, and isolated withdrawal do not account for this characteristic combination.

11. A patient with opioid toxicity has severe respiratory depression and unstable cardiovascular function. Which management approach best reflects the priorities for this toxicity?

Support respiratory and cardiovascular function, decontaminate, and use an opioid antagonist to reverse respiratory depression
Decontaminate and use an opioid antagonist, while deferring respiratory and cardiovascular support
Support respiratory and cardiovascular function and observe, without considering decontamination or antagonists
Sedate and observe while avoiding interventions directed at respiratory depression

Support respiratory and cardiovascular function, decontaminate, and use an opioid antagonist to reverse respiratory depression

Explanation

Management includes maintaining respiratory and cardiovascular function, decontamination, and opioid antagonists to reverse respiratory depression. Decontamination alone, antagonist use without vital-function support, or observation alone omits essential management priorities.

12. A drug produces effects resembling stimulation of the sympathetic nervous system, with activity that may be directed mainly at adrenergic alpha or beta receptors. What category describes it?

A sympathomimetic drug
An adrenergic alpha receptor
A catecholamine neurotransmitter
A parasympathomimetic drug

A sympathomimetic drug

Explanation

Sympathomimetic drugs produce effects similar to stimulation of the sympathetic nervous system; some act mainly on adrenergic alpha receptors and others on beta receptors. Parasympathetic effects, a receptor subtype, and a neurotransmitter are not the drug category defined here.

13. After taking a stimulant, a patient develops a rapid heart rate, elevated blood pressure, heavy sweating, high temperature, agitation, and combative behavior. Which toxicity pattern best matches these findings?

Opioid toxicity
Sedative toxicity
Sympathomimetic toxicity
Gastrointestinal toxicity

Sympathomimetic toxicity

Explanation

Tachycardia, hypertension, diaphoresis, hyperthermia, agitation, and combativeness are characteristic signs of sympathomimetic toxicity. Opioid toxicity is associated with depression and miosis, while the other choices do not account for this sympathetic pattern.

14. A drug increases synaptic activity in dopamine and norepinephrine systems and also acts as a stimulant and appetite suppressant. Which drug group best fits this mechanism and profile?

Xanthine derivatives
Amphetamines
Opioid antagonists
Cocaine

Amphetamines

Explanation

Amphetamines stimulate the central nervous system by increasing synaptic activity in dopamine and norepinephrine systems, and they act as stimulants and appetite suppressants. Cocaine’s stated toxicity mechanism also includes sodium-channel inhibition, while opioid antagonists and xanthine derivatives do not match this description.

15. A laboratory analysis of cocaine toxicity identifies both enhanced catecholamine action and interference with voltage-dependent sodium channels. Which mechanism best explains the findings?

Potentiation of catecholamine action together with activation of voltage-dependent sodium channels
Potentiation of catecholamine action together with inhibition of voltage-dependent sodium channels
Inhibition of catecholamine action together with activation of voltage-dependent sodium channels
Increased catecholamine synthesis together with inhibition of voltage-dependent sodium channels

Potentiation of catecholamine action together with inhibition of voltage-dependent sodium channels

Explanation

Cocaine toxicity potentiates catecholamine action, including dopamine and norepinephrine, and inhibits voltage-dependent sodium ion channels. The alternatives either reverse the channel effect, replace potentiation with synthesis, or reverse both mechanisms.

16. Which description best defines xanthine derivatives?

Agents that inhibit voltage-dependent sodium ion channels
Agents that block acetylcholine receptors and inhibit parasympathetic transmission
Agents resembling natural xanthines such as caffeine, theobromine, and theophylline
Agents that enhance catecholamine action, including dopamine and norepinephrine

Agents resembling natural xanthines such as caffeine, theobromine, and theophylline

Explanation

Xanthine derivatives resemble naturally occurring xanthines, including caffeine, theobromine, and theophylline. Acetylcholine-receptor blockers, catecholamine enhancers, and sodium-channel blockers describe different drug actions.

17. A patient with suspected xanthine derivative toxicity develops agitation and dizziness. Which additional finding is also consistent with this toxicity?

Dyspnea
Hypertension
Dry mouth
Arrhythmia

Arrhythmia

Explanation

Xanthine derivative toxicity can cause arrhythmias, along with seizures, headache, hypotension, dizziness, and agitation. Dry mouth and dyspnea are associated with anticholinergic toxicity, while hypertension is noted with cocaine toxicity in the course material.

18. What action characterizes an anticholinergic agent?

Enhancing catecholamine action and increasing sympathetic nerve transmission
Activating acetylcholine receptors and increasing parasympathetic nerve transmission
Blocking adrenergic receptors and inhibiting sympathetic nerve transmission
Blocking acetylcholine receptors and inhibiting parasympathetic nerve transmission

Blocking acetylcholine receptors and inhibiting parasympathetic nerve transmission

Explanation

Anticholinergic agents block acetylcholine receptors, inhibiting parasympathetic nerve impulses; they are also called antimuscarinic agents or cholinergic blockers. Receptor activation reverses the mechanism, while adrenergic blockade and catecholamine enhancement describe other actions.

19. A conscious patient arrives 40 minutes after ingesting an anticholinergic drug. Which management approach matches the recommended early care?

Administer physostigmine as the routine first-line treatment
Provide supportive care, consider gastric lavage, and give activated charcoal to reduce absorption
Give benzodiazepines as the primary absorption-reduction treatment
Provide supportive care and defer gastric lavage because its useful window has passed

Provide supportive care, consider gastric lavage, and give activated charcoal to reduce absorption

Explanation

Most anticholinergic toxicity cases require supportive care; gastric lavage may be useful within one hour, and activated charcoal can reduce absorption in a conscious patient. Deferring lavage misreads the time window, benzodiazepines do not reduce absorption, and physostigmine is not routine first-line treatment.

20. A patient with anticholinergic toxicity has a cyclic antidepressant overdose and a history of heart block. Which decision about physostigmine is appropriate?

Use physostigmine because it reverses anticholinergic effects despite these risks
Avoid physostigmine because the overdose and heart block are contraindications
Use physostigmine at a reduced dose because only bronchospasm is a concern
Replace supportive care with physostigmine because heart block is not relevant

Avoid physostigmine because the overdose and heart block are contraindications

Explanation

Physostigmine should be avoided in cyclic antidepressant overdose because it may potentiate toxicity and increase mortality, and heart block is also a contraindication. Giving it despite either risk overlooks the stated safety restrictions; supportive care remains the general approach.

21. A patient with a tricyclic antidepressant overdose develops worsening neurologic and cardiac symptoms. Which set of manifestations is characteristic of this toxicity?

Polyuria, flank pain, and progressive edema
Pinpoint pupils, respiratory depression, and bradycardia
CNS depression, seizures, and cardiac arrhythmias
Abdominal pain, diarrhea, and electrolyte depletion

CNS depression, seizures, and cardiac arrhythmias

Explanation

Tricyclic antidepressant toxicity can produce CNS depression, seizures, and cardiac arrhythmias. The gastrointestinal, opioid-like, and renal symptom clusters do not describe this characteristic combination.

22. Which patient group should raise particular concern for serious toxicity after tricyclic antidepressant exposure?

Patients with asthma, skin disorders, and uncomplicated infections
Children, elderly people, and cardiac patients
People taking SSRIs, antacids, and antihistamines
Healthy adults, athletes, and patients with seasonal allergies

Children, elderly people, and cardiac patients

Explanation

Serious tricyclic antidepressant toxicity can occur in children, elderly people, and cardiac patients. The other groups replace these specified risk populations with unrelated characteristics or medication use.

23. After an SSRI overdose, a patient develops hyperthermia, muscle rigidity, altered vital signs, and a changed mental state. Which toxicity syndrome best fits this presentation?

A sedative-hypnotic toxidrome
A primary cardiac arrhythmia syndrome
An anticholinergic syndrome
Serotonin syndrome

Serotonin syndrome

Explanation

Hyperthermia, muscle rigidity, altered vital signs, and changed mental status are features of serotonin syndrome in SSRI toxicity. A cardiac arrhythmia alone, anticholinergic toxicity, or sedative-related depression does not account for this characteristic cluster.

24. A patient with SSRI toxicity weighs 60 kg. Which initial activated-charcoal dose and monitoring plan match the listed management?

1 g orally or by nasogastric tube, with cardiovascular and respiratory monitoring every 12 hours for up to 6 days
60 g orally or by nasogastric tube, with cardiovascular and respiratory monitoring once daily for up to 6 days
60 g orally or by nasogastric tube, with cardiovascular and respiratory monitoring every 12 hours for up to 10 days
60 g orally or by nasogastric tube, with cardiovascular and respiratory monitoring every 12 hours for up to 6 days

60 g orally or by nasogastric tube, with cardiovascular and respiratory monitoring every 12 hours for up to 6 days

Explanation

The charcoal dose is 1 g/kg1\,\text{g/kg}, so a 60 kg patient receives 60 g; cardiovascular and respiratory functions are monitored every 12 hours for up to 6 days. A 1 g total dose ignores body weight, daily checks reduce the stated frequency, and 10 days exceeds the listed duration.

25. A patient with SSRI toxicity is prescribed cyproheptadine. Which regimen matches the listed antidote schedule?

4–8 mg intravenously every 2 hours until favorable effect, then 4 mg intravenously every 6 hours for 48 hours
4 mg orally every 6 hours until favorable effect, then 4–8 mg orally every 2 hours for 48 hours
4–8 mg orally every 2 hours until favorable effect, then 4 mg orally every 6 hours for 48 hours
4 mg orally every 2 hours until favorable effect, then 8 mg orally every 6 hours for 48 hours

4–8 mg orally every 2 hours until favorable effect, then 4 mg orally every 6 hours for 48 hours

Explanation

Cyproheptadine is given orally at 4–8 mg every 2 hours until a favorable effect is noted, followed by 4 mg orally every 6 hours for 48 hours. The other regimens reverse the intervals, alter the stated doses, or use an unsupported route.

Study with flashcards

Lock in the answers with 60 flashcards on Therapeutic Agent Toxicology.

How does the therapeutic index of benzodiazepines compare with barbiturates?

Benzodiazepines have a higher therapeutic index.

What key property of benzodiazepines promoted their substitution for barbiturates?

They lack anesthetic properties.

What does benzodiazepine toxicity mainly depress?

The central nervous system.

See the flashcards →

Read the study guide

Go over the full study guide for Therapeutic Agent Toxicology.

Read the study guide →

Related classes

Make your own practice quizzes

Upload your class notes and Revizly writes a practice quiz with explained answers in about a minute.

Quiz maker